Skip to main content

8 Result(s)

within B. H. Mitlak Remove this filter

and

  1. Article

    Open Access

    Bone turnover markers to explain changes in lumbar spine BMD with abaloparatide and teriparatide: results from ACTIVE

    Early PINP changes correlate with 18-month lumbar spine BMD changes and the correlation was greater with abaloparatide versus teriparatide. The uncoupling index was similar between the two agents.

    R. Eastell, B. H. Mitlak, Y. Wang, M. Hu, L. A. Fitzpatrick… in Osteoporosis International (2019)

    Download PDF (840 KB) View Article

  2. No Access

    Article

    FRAX and the effect of teriparatide on vertebral and non-vertebral fracture

    Daily teriparatide injections have been shown to reduce vertebral and non-vertebral fractures. Here, we demonstrate that the magnitude of fracture risk reduction is independent of baseline fracture probability...

    N. C. Harvey, J. A. Kanis, A. Odén, R. T. Burge, B. H. Mitlak… in Osteoporosis International (2015)

  3. No Access

    Article

    The effect of teriparatide compared with risedronate on reduction of back pain in postmenopausal women with osteoporotic vertebral fractures

    The effect of teriparatide and risedronate on back pain was tested, and there was no difference in the proportion of patients experiencing a reduction in back pain between groups after 6 or 18 months. Patients...

    P. Hadji, J. R. Zanchetta, L. Russo, C. P. Recknor… in Osteoporosis International (2012)

  4. No Access

    Article

    The need for a transparent, ethical, and successful relationship between academic scientists and the pharmaceutical industry: a view of the Group for the Respect of Ethics and Excellence in Science (GREES)

    This paper provides recommendations for fair and unbiased relationship between academic scientists and the pharmaceutical industry.

    O. Bruyere, J. A. Kanis, M.-E. Ibar-Abadie, N. Alsayed… in Osteoporosis International (2010)

  5. No Access

    Article

    Evaluation of vertebral fracture assessment by dual X-ray absorptiometry in a multicenter setting

    The utility of vertebral fracture assessment (VFA) by DXA to detect prevalent vertebral fracture in a multicenter setting was investigated by comparison to conventional radiography. While limited by lower imag...

    T. Fuerst, C. Wu, H. K. Genant, G. von Ingersleben, Y. Chen… in Osteoporosis International (2009)

  6. No Access

    Article

    Effectiveness of instant vertebral assessment to detect prevalent vertebral fracture

    Vertebral fracture is currently underdiagnosed, despite its common severity and its value to predict further osteoporotic fracture. Morphometry using dual X-ray absorptiometry (DXA) [vertebral fracture assessm...

    R. D. Chapurlat, F. Duboeuf, H. O. Marion-Audibert… in Osteoporosis International (2006)

  7. No Access

    Article

    Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy

    Teriparatide (rhPTH[1-34]), a bone-forming agent for the treatment of osteoporosis, increases bone mineral density in men and women, and reduces the risk of fractures in women with osteoporosis. However, fract...

    J.-M. Kaufman, E. Orwoll, S. Goemaere, J. San Martin… in Osteoporosis International (2005)

  8. No Access

    Article

    Geographic Differences in Bone Turnover: Data from a Multinational Study in Healthy Postmenopausal Women

    Biochemical markers of bone metabolism (bone markers) are used increasingly to monitor response to therapy and may be predictors of bone loss and fractures. The relationship between fracture rates, which diff...

    F. J. Cohen, S. Eckert, B. H. Mitlak in Calcified Tissue International (1998)